January 14, 2015

The University of Florida's Pharm.D. program recently released an infographic around the risks associated with acetaminophen use. 

January 9, 2015

NeuroMetrix is making a splash at this year's International Consumer Electronics Show with its launch of Quell, an OTC chronic pain relieving device.

December 11, 2014

Australian Dream is one of those hot external analgesic products that has been growing by greater than 20% across all channels. Drug Store News had an opportunity to dig a little deeper regarding the Nature s Health Connection s Australian Dream product with David Biernbaum of David Biernbaum and Assoc., who represents the product.

December 11, 2014

External analgesics is a category replete with growth brands with a base of $497.8 million across total U.S. multi-outlets, and more than 8.1% in growth for the 52 weeks ended Sept. 7, according to IRI data.

December 9, 2014

From 2009 to 2013, the number of Americans using prescription opiates declined 9.2%, yet both the number of opioid prescriptions filled and the number of days of medication per prescription rose more than 8% in that time period. 

December 8, 2014

The pros of giving healthy women regular low dose aspirin to stave off such serious illness as cancer and heart disease are outweighed by the cons, suggests a large study published online last week in the journal Heart.

November 21, 2014

A study being published in Annals of Internal Medicine suggests that people with atrial fibrillation who take NSAIDs may be at risk for serious bleeding or thromboembolisms. 

November 20, 2014

Purdue Pharma on Thursday announced that the Food and Drug Administration approved Hysingla ER (hydrocodone bitartrate) extended‐release tablets CII, a once‐daily, single‐entity medication formulated using Purdue’s proprietary extended‐release solid oral platform, Resistec.

November 18, 2014

Chattem on Tuesday announced that IcyHot SmartRelief, a drug-free, over-the-counter pain management system, is now available nationwide.

October 27, 2014

Prestige Brands on Monday reiterated that it is expanding its partnership between Goody's and NASCAR driver Dale Earnhardt Jr.

October 23, 2014

Preliminary results of an open-label trial carried Thursday in the journal of Headache and Pain reported that a single treatment with ElectroCore’s hand held non-invasive vagus nerve stimulation device GammaCore, completely resolved 44.8% of migraines within 30 minutes.

October 21, 2014

Over-the-counter painkillers and anti-inflammatory drugs may also be effective in the treatment of people suffering from depression.

 

October 15, 2014

The resurgence of iconic pain relief brands Tylenol and Excedrin continue to contribute to the slight growth across internal analgesic tablets. It’s a $3.2 billion book of business across U.S. multi-outlets, according to IRI, that is up slightly by 0.8% for the 52 weeks ended Aug. 10. 

September 15, 2014

Bayer HealthCare on Monday launched Aleve PM, the first over-the-counter nighttime product with a safe sleep aid plus the 12-hour pain-relieving strength of Aleve.

September 10, 2014

SpiderTech recently announced the launch of its pre-cut kinesiology tape that provides drug-free relief for anyone suffering from minor aches and pain.

September 5, 2014

Purdue Pharma on Thursday shared results from several studies evaluating its investigational pain medication Hysingla ER.

August 27, 2014

Low-dose aspirin lowers the occurrence of new venous blood clots — and represents a reasonable treatment option for patients who are not candidates for long-term anticoagulant drugs, such as warfarin, according to a new study published in Monday's issue of Circulation.

August 22, 2014

The Drug Enforcement Administration issued a final rule rescheduling hydrocodone combination products from schedule III to schedule II of the Controlled Substances Act.

August 20, 2014

Wahl is differentiating itself from other products on the shelf through a new approach that combines a massager with hot-cold gel packs, helping to increase circulation and reduce swelling.

August 20, 2014

The lion’s share of the analgesics business may be in internal analgesics — sales of which totaled $3.6 billion, up 1.1% for the 52 weeks ended June 15 across total U.S. multi-outlets, according to IRI — but it’s alternative pain relievers that may represent the growth opportunity.

August 20, 2014

Excedrin relaunched in the United States in 2013 and is doing well. The brand generated $130 million between its Excedrin tablets and Excedrin Migraine tablets for the 52 weeks ended June 15 across total U.S. multi-outlets, according to IRI.

August 20, 2014

Who is the alternative analgesic pain consumer? “The majority of these people [in search of external pain relief] have chronic pain and are already taking prescriptions and using multiple methods of pain relief,” said Jenny McLaughlin, product manager for Walh Therapeutic Massagers. “Our research shows people are coming into the health-and-wellness area once a month.”

August 20, 2014

Perfecta Products last year added Zim’s Arnica Max to it’s lineup of external analgesic rubs, which includes Zim’s Max-Freeze, an $11.8 million brand grew 27.3% for the 52 weeks ended June 15 across total U.S. multi-outlets, according to IRI.

August 20, 2014

The entire external analgesic category is up 6.7%, reaching a base of $486.9 million across total U.S. multi-outlets for the 52 weeks ended June 15, according to IRI data. And Salonpas, with a 10.9% dollar share, is helping to drive that growth with positive sales gains of 28.7% to $52.9 million.